| Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ... Emerging infectious diseases 26 (7), 1478, 2020 | 1616 | 2020 |
| Clinical and virological data of the first cases of COVID-19 in Europe: a case series FX Lescure, L Bouadma, D Nguyen, M Parisey, PH Wicky, S Behillil, ... The Lancet Infectious Diseases 20 (6), 697-706, 2020 | 1334 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 430 | 2021 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ... Science translational medicine 12 (559), eabc3103, 2020 | 336* | 2020 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 325 | 2021 |
| Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort N Néant, G Lingas, Q Le Hingrat, J Ghosn, I Engelmann, Q Lepiller, ... Proceedings of the National Academy of Sciences 118 (8), e2017962118, 2021 | 199 | 2021 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 127 | 2022 |
| Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 … H Tarhini, A Recoing, A Bridier-Nahmias, M Rahi, C Lambert, P Martres, ... The Journal of infectious diseases 223 (9), 1522-1527, 2021 | 112 | 2021 |
| Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection B Visseaux, Q Le Hingrat, G Collin, D Bouzid, S Lebourgeois, D Le Pluart, ... Journal of clinical microbiology 58 (8), 10.1128/jcm. 00630-20, 2020 | 105 | 2020 |
| Illegal gold miners in French Guiana: a neglected population with poor health M Douine, E Mosnier, Q Le Hingrat, C Charpentier, F Corlin, L Hureau, ... BMC public health 18, 1-10, 2018 | 101 | 2018 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 80 | 2021 |
| Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives Q Le Hingrat, B Visseaux, C Laouenan, S Tubiana, L Bouadma, ... Clinical Microbiology and Infection 27 (5), 789. e1-789. e5, 2021 | 63 | 2021 |
| Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali A Jary, S Dienta, V Leducq, Q Le Hingrat, M Cisse, AB Diarra, DB Fofana, ... BMC Infectious Diseases 19, 1-8, 2019 | 52 | 2019 |
| Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification N Désiré, L Cerutti, Q Le Hingrat, M Perrier, S Emler, V Calvez, ... Retrovirology 15, 1-7, 2018 | 51 | 2018 |
| Prevalence of human papillomavirus, human immunodeficiency virus, and other sexually transmitted infections among men who have sex with men in Togo: a national cross-sectional … VM Ferré, FA Gbeasor-Komlanvi, G Collin, AC Dagnra, Q Le Hingrat, ... Clinical Infectious Diseases 69 (6), 1019-1026, 2019 | 47 | 2019 |
| Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection B Visseaux, Q Le Hingrat, G Collin, V Ferré, A Storto, H Ichou, D Bouzid, ... Journal of Clinical Virology 129, 104520, 2020 | 45 | 2020 |
| Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection H Tarhini, A Recoing, A Bridier-Nahmias, M Rahi, C Lambert, P Martres, ... J Infect Dis 223 (9), 1522-1527, 2021 | 40 | 2021 |
| Case report study of the first five COVID-19 patients treated with remdesivir in France M Dubert, B Visseaux, V Isernia, L Bouadma, L Deconinck, J Patrier, ... International journal of infectious diseases 98, 290-293, 2020 | 40 | 2020 |
| Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients M Perrier, M Bertine, Q Le Hingrat, V Joly, B Visseaux, G Collin, ... Journal of Antimicrobial Chemotherapy 72 (10), 2954-2955, 2017 | 33 | 2017 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 32 | 2021 |
